George K Ng insider trades

Open-market stock purchases and sales by George K Ng, Chief Executive Officer at Processa Pharmaceuticals, Inc, from SEC Form 4 filings since Aug 3, 2015.

Track record: 9% of 11 scored buys are up 5% or more since purchase, averaging -8%.

Recent trades

DateStockTradeValue
Jun 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
May 29, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
May 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
Apr 30, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
Apr 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
Apr 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
Apr 15, 2026PCSA Processa Pharmaceuticals, IncBought$5.5K
Mar 31, 2026PCSA Processa Pharmaceuticals, IncBought$5.4K
Mar 31, 2026PCSA Processa Pharmaceuticals, IncBought$5.4K
Feb 12, 2026HURA TuHURA Biosciences, Inc./NVBought (not open market)—

Companies traded

  • PCSA Processa Pharmaceuticals, Inc: 11 buys, last Jun 15, 2026
  • HURA TuHURA Biosciences, Inc./NV: other filings, last Feb 12, 2026
  • KTRA Kintara Therapeutics, Inc: other filings, last Oct 18, 2024
  • SRNE Sorrento Therapeutics, Inc: 5 buys, 1 sale, last Feb 28, 2018

Get free alerts when George K Ng files a new trade →